{
  "id": "8eac7786e74545a2",
  "title": "Cogent Biosciences to Initiate New Drug Application ( NDA ) \u00a0Submission for\u00a0Bezuclastinib Under\u00a0Real - Time Oncology Review ( RTOR ) ",
  "description": "20260120T140000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/cogent-biosciences-to-initiate-new-drug-application-ndasubmission-forbezuclastinib-underreal-time-oncology-review-rtor/2261802",
  "published_at": "20260120T140000Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/cogent-biosciences-to-initiate-new-drug-application-ndasubmission-forbezuclastinib-underreal-time-oncology-review-rtor/2261802",
    "url_mobile": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/cogent-biosciences-to-initiate-new-drug-application-ndasubmission-forbezuclastinib-underreal-time-oncology-review-rtor/2261802/amp",
    "title": "Cogent Biosciences to Initiate New Drug Application ( NDA ) \u00a0Submission for\u00a0Bezuclastinib Under\u00a0Real - Time Oncology Review ( RTOR ) ",
    "seendate": "20260120T140000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/20/906015.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}